<DOC>
	<DOCNO>NCT02539030</DOCNO>
	<brief_summary>This study design evaluate efficacy safety modify microfracture use collagen , compare simple microfracture prove non-inferiority modify microfracture use collagen patient cartilage defect knee .</brief_summary>
	<brief_title>Comparison Efficacy Safety Microfracture Modified Microfracture</brief_title>
	<detailed_description>This study open-trial study . One hundred subject participate . The study explain subject voluntarily agree participate . Their eligibility participate study check , randomize either simple microfracture group modify microfracture group use collagen base centrally control randomization table . They ask follow guideline investigator study visit hospital six times* , include screening . At visit , subject underwent examination doctor , blood test , X-ray procedure , MRI , observation naked eye , arthroscopy evaluate safety efficacy procedure . ( *If screening date overlap procedure date , number visit would five . )</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Cartilage Diseases</mesh_term>
	<criteria>1 . Patients cartilage defect knee ( Including Knee OA Knee TA ) 2 . Knee osteoarthritis patient whose KellgrenLawrence Grading Scale score low 3 ( patient receive simultaneous previous correction exclude ) . 3 . Patients misalignment tibia femur , unstable ligament knee , bony defect lesion knee , and/or treat alignment 4 . Patients 15 year old old 5 . Patients representative ( adult ) , patient parent/guardian ( minor ) , agree participate study sign informed consent form 1 . If patient family suffer ever suffer autoimmune disease . 2 . Patients ever suffer anaphylactic reaction . 3 . Patients ever suffer hypersensitivity implant . 4 . Patients history allergy porcine bovine protein . 5 . Subjects inflammatory arthritis , rheumatoid gouty arthritis . 6 . Subjects autoimmune disease relate arthritis . 7 . Subjects pregnant and/or breastfeed and/or plan pregnancy . 8 . Subjects tumor . 9 . Subjects undergone radiotherapy chemotherapy within last 2 year ( Exception : possibility collagen treatment confirm doctor 's clinical decision ) . 10 . Subjects diabetic . ( Exception : possibility CartiFillâ„¢ treatment confirm doctor 's clinical decision , and/or patient 's blood glucose level remain within normal range and/or complication diabetes mellitus . ) 11 . Subjects infection , currently treatment antibiotic antimicrobial ( Exception : possibility collagen treatment confirm doctor 's clinical decision ) . 12 . Subjects adrenocorticoid therapy ( Exception : possibility collagen treatment confirm doctor 's clinical decision ) . 13 . Subjects psychiatric disorder consider inappropriate participate trial Principal Investigator . 14 . Patients ever suffer contraindication use Fibrin sealant . ( The major contraindication follow : patient hypersensitivity aprotinin treatment severe brisk arterial venous bleeding . )</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Cartilage defect knee</keyword>
	<keyword>microfracture</keyword>
	<keyword>modify microfracture</keyword>
	<keyword>collagen</keyword>
</DOC>